Skip to main content
Top
Published in: World Journal of Urology 1/2024

01-12-2024 | Original Article

The influence of socioeconomic status and gender on incidence and survival in bladder cancer: a longitudinal study based on the Hamburg Cancer Registry

Authors: Clemens M. Rosenbaum, Simon Filmar, Andreas J. Gross, Niklas Jobst, Annemarie Schultz

Published in: World Journal of Urology | Issue 1/2024

Login to get access

Abstract

Background

To investigate the influence of socioeconomic status (SES) and gender on the incidence and survival of patients with bladder cancer on a small scale within the city of Hamburg, Germany.

Methods

Patients documented in the Hamburg Cancer Registry aged ≥ 18 years with primary bladder carcinoma (ICD-10: C67, D09.0), diagnosed in the period 2004–2020 (follow-up until 31.12.2021), and residing in Hamburg were included. The patients were divided into three groups (low, intermediate, and high SES) based on the socioeconomic situation at the district level, defined by the proportion of unemployed individuals, social housing, benefit recipients according to law, etc. Relative survival in the years 2004–2020 was calculated using a period approach.

Results

Among the 10,659 patients included, age-standardized 5-year relative survival (5YRS) in 2004–2020 correlated with SES. The age-standardized 5YRS differed significantly between patients with high and intermediate SES vs low SES. Women with low SES had the worst 5YRS at 58.2%, while men with high SES presented the best relative 5YRS at 73.5%. This effect remained after stratification by UICC stages. Concerning incidence, there is an indication that women with low SES were more often diagnosed in higher UICC stages III or IV than women with high SES (18.3% versus 12.6%).

Conclusions

The socioeconomic situation at the time of diagnosis, as well as gender, has a substantial impact on the incidence and cancer survival rates in patients with bladder cancer. Further research, including the study of patient care, is needed to better understand and address these inequalities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jansen L, Behrens G, Finke I, Maier W, Gerken M, Pritzkuleit R et al (2020) Area-based socioeconomic inequalities in colorectal cancer survival in Germany: investigation based on population-based clinical cancer registration. Front Oncol 10:857CrossRefPubMedPubMedCentral Jansen L, Behrens G, Finke I, Maier W, Gerken M, Pritzkuleit R et al (2020) Area-based socioeconomic inequalities in colorectal cancer survival in Germany: investigation based on population-based clinical cancer registration. Front Oncol 10:857CrossRefPubMedPubMedCentral
2.
go back to reference Jansen L, Erb C, Nennecke A, Finke I, Pritzkuleit R, Holleczek B et al (2021) Socioeconomic deprivation and cancer survival in a metropolitan area: an analysis of cancer registry data from Hamburg. Germany Lancet Reg Health Eur 4:100063CrossRefPubMed Jansen L, Erb C, Nennecke A, Finke I, Pritzkuleit R, Holleczek B et al (2021) Socioeconomic deprivation and cancer survival in a metropolitan area: an analysis of cancer registry data from Hamburg. Germany Lancet Reg Health Eur 4:100063CrossRefPubMed
3.
go back to reference Woods LM, Rachet B, Coleman MP (2006) Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 17(1):5–19CrossRefPubMed Woods LM, Rachet B, Coleman MP (2006) Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 17(1):5–19CrossRefPubMed
4.
go back to reference Mackillop WJ, Zhang-Salomons J, Groome PA, Paszat L, Holowaty E (1997) Socioeconomic status and cancer survival in Ontario. J Clin Oncol 15(4):1680–1689CrossRefPubMed Mackillop WJ, Zhang-Salomons J, Groome PA, Paszat L, Holowaty E (1997) Socioeconomic status and cancer survival in Ontario. J Clin Oncol 15(4):1680–1689CrossRefPubMed
5.
go back to reference Russell B, Hemelrijck MV, Gardmark T, Holmberg L, Kumar P, Bellavia A et al (2020) A mediation analysis to explain socio-economic differences in bladder cancer survival. Cancer Med 9(20):7477–7487CrossRefPubMedPubMedCentral Russell B, Hemelrijck MV, Gardmark T, Holmberg L, Kumar P, Bellavia A et al (2020) A mediation analysis to explain socio-economic differences in bladder cancer survival. Cancer Med 9(20):7477–7487CrossRefPubMedPubMedCentral
6.
go back to reference Begum G, Dunn JA, Bryan RT, Bathers S, Wallace DM, West Midlands Urological Research G (2004) Socio-economic deprivation and survival in bladder cancer. BJU Int. 94(4):539–43CrossRefPubMed Begum G, Dunn JA, Bryan RT, Bathers S, Wallace DM, West Midlands Urological Research G (2004) Socio-economic deprivation and survival in bladder cancer. BJU Int. 94(4):539–43CrossRefPubMed
7.
go back to reference Jacobs BL, Montgomery JS, Zhang Y, Skolarus TA, Weizer AZ, Hollenbeck BK (2012) Disparities in bladder cancer. Urol Oncol 30(1):81–88CrossRefPubMed Jacobs BL, Montgomery JS, Zhang Y, Skolarus TA, Weizer AZ, Hollenbeck BK (2012) Disparities in bladder cancer. Urol Oncol 30(1):81–88CrossRefPubMed
8.
go back to reference Ueda K, Kawachi I, Tsukuma H (2006) Cervical and corpus cancer survival disparities by socioeconomic status in a metropolitan area of Japan. Cancer Sci 97(4):283–291CrossRefPubMed Ueda K, Kawachi I, Tsukuma H (2006) Cervical and corpus cancer survival disparities by socioeconomic status in a metropolitan area of Japan. Cancer Sci 97(4):283–291CrossRefPubMed
9.
go back to reference Teoh JY, Huang J, Ko WY, Lok V, Choi P, Ng CF et al (2020) Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur Urol 78(6):893–906CrossRefPubMed Teoh JY, Huang J, Ko WY, Lok V, Choi P, Ng CF et al (2020) Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur Urol 78(6):893–906CrossRefPubMed
10.
go back to reference Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH (2010) The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 105(3):300–308CrossRefPubMed Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH (2010) The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 105(3):300–308CrossRefPubMed
13.
go back to reference Ederer FaHH. Instructions to IBM 650 Programmers in Processing Survival Computations. Bethesda, MD: National Cancer Institute; 1959 Methodological note no 10 End Results Evaluation Section. 1959. Ederer FaHH. Instructions to IBM 650 Programmers in Processing Survival Computations. Bethesda, MD: National Cancer Institute; 1959 Methodological note no 10 End Results Evaluation Section. 1959.
14.
go back to reference Brenner H, Gefeller O, Hakulinen T (2004) Period analysis for “up-to-date” cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 40(3):326–335CrossRefPubMed Brenner H, Gefeller O, Hakulinen T (2004) Period analysis for “up-to-date” cancer survival data: theory, empirical evaluation, computational realisation and applications. Eur J Cancer 40(3):326–335CrossRefPubMed
15.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457CrossRef
16.
go back to reference Babjuk M, Burger M, Capoun O, Cohen D, Comperat EM, Dominguez Escrig JL et al (2022) European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol 81(1):75–94CrossRefPubMed Babjuk M, Burger M, Capoun O, Cohen D, Comperat EM, Dominguez Escrig JL et al (2022) European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol 81(1):75–94CrossRefPubMed
17.
go back to reference Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A et al (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72(5):409–436CrossRefPubMed Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A et al (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72(5):409–436CrossRefPubMed
18.
go back to reference Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72(1):7–33CrossRefPubMed Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72(1):7–33CrossRefPubMed
19.
go back to reference Uhlig A, Seif Amir Hosseini A, Simon J, Lotz J, Trojan L, Schmid M et al (2018) Gender specific differences in disease-free, cancer specific and overall survival after radical cystectomy for bladder cancer: a systematic review and meta-analysis. J Urol. 200(1):48–60CrossRefPubMed Uhlig A, Seif Amir Hosseini A, Simon J, Lotz J, Trojan L, Schmid M et al (2018) Gender specific differences in disease-free, cancer specific and overall survival after radical cystectomy for bladder cancer: a systematic review and meta-analysis. J Urol. 200(1):48–60CrossRefPubMed
20.
go back to reference Gul ZG, Liaw CW, Mehrazin R (2021) Gender differences in incidence, diagnosis, treatments, and outcomes in clinically localized bladder and renal cancer. Urology 151:176–181CrossRefPubMed Gul ZG, Liaw CW, Mehrazin R (2021) Gender differences in incidence, diagnosis, treatments, and outcomes in clinically localized bladder and renal cancer. Urology 151:176–181CrossRefPubMed
21.
go back to reference Madeb R, Messing EM (2004) Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 22(2):86–92CrossRefPubMed Madeb R, Messing EM (2004) Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 22(2):86–92CrossRefPubMed
22.
go back to reference Marks P, Soave A, Shariat SF, Fajkovic H, Fisch M, Rink M (2016) Female with bladder cancer: what and why is there a difference? Transl Androl Urol 5(5):668–682CrossRefPubMedPubMedCentral Marks P, Soave A, Shariat SF, Fajkovic H, Fisch M, Rink M (2016) Female with bladder cancer: what and why is there a difference? Transl Androl Urol 5(5):668–682CrossRefPubMedPubMedCentral
23.
go back to reference Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG, Rink M et al (2016) Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. BJU Int 117(2):272–279CrossRefPubMed Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG, Rink M et al (2016) Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. BJU Int 117(2):272–279CrossRefPubMed
24.
go back to reference May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W et al (2013) Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol 31(7):1141–1147CrossRefPubMed May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W et al (2013) Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol 31(7):1141–1147CrossRefPubMed
25.
go back to reference Henning A, Wehrberger M, Madersbacher S, Pycha A, Martini T, Comploj E et al (2013) Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int 112(1):68–73CrossRefPubMed Henning A, Wehrberger M, Madersbacher S, Pycha A, Martini T, Comploj E et al (2013) Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int 112(1):68–73CrossRefPubMed
26.
go back to reference Garg T, Pinheiro LC, Atoria CL, Donat SM, Weissman JS, Herr HW et al (2014) Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. J Urol 192(4):1072–1077CrossRefPubMedPubMedCentral Garg T, Pinheiro LC, Atoria CL, Donat SM, Weissman JS, Herr HW et al (2014) Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. J Urol 192(4):1072–1077CrossRefPubMedPubMedCentral
27.
go back to reference Arndt V, Holleczek B, Kajuter H, Luttmann S, Nennecke A, Zeissig SR et al (2020) Data from population-based cancer registration for secondary data analysis: methodological challenges and perspectives. Gesundheitswesen. 82(S01):S62–S71PubMed Arndt V, Holleczek B, Kajuter H, Luttmann S, Nennecke A, Zeissig SR et al (2020) Data from population-based cancer registration for secondary data analysis: methodological challenges and perspectives. Gesundheitswesen. 82(S01):S62–S71PubMed
28.
go back to reference Katalinic A, Halber M, Meyer M, Pflüger M, Eberle A, Nennecke A et al (2023) Population-based clinical cancer registration in Germany. Cancers 15(15):3934CrossRefPubMedPubMedCentral Katalinic A, Halber M, Meyer M, Pflüger M, Eberle A, Nennecke A et al (2023) Population-based clinical cancer registration in Germany. Cancers 15(15):3934CrossRefPubMedPubMedCentral
Metadata
Title
The influence of socioeconomic status and gender on incidence and survival in bladder cancer: a longitudinal study based on the Hamburg Cancer Registry
Authors
Clemens M. Rosenbaum
Simon Filmar
Andreas J. Gross
Niklas Jobst
Annemarie Schultz
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 1/2024
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-024-04888-4

Other articles of this Issue 1/2024

World Journal of Urology 1/2024 Go to the issue